Investor Relations | Taisho Pharmaceutical Co., Ltd.


	Aug 4, 2010		Presentation of Fiscal 2010 First Quarter Results

	Jul 30, 2010		Discontinuation of Development of TS-022 for Treatment of Atopic Dermatitis with Pruritus

	Jul 30, 2010		Financial Results for the First Quarter of Fiscal 2010 / Reference Data

IR Library

Adobe Reader is required to view these files. Adobe Reader is distributed free of charge by Adobe Systems Incorporated.